Tahoe's co-founders describe how Tahoe-100M enables therapeutic discoveries on BiotechTV

Authored by

Released on

March 17, 2025

Authored by

Released on

March 17, 2025

Summary

Our Work

Latest from our team

Tahoe Therapeutics and Alloy Therapeutics to Form Joint Venture and Develop First-in-Class Antibody-Drug Conjugates for Hard-to-Treat Cancers

Announcing our partnership with Arc Institute and Biohub

Tahoe Therapeutics, Arc Institute, and Biohub Partner to Generate the Largest Perturbation Dataset for Virtual Cell Models

Tahoe welcomes drug discovery veterans Wayne Spevak, Ph.D., and Ben Powell, Ph.D., to leadership team

Introducing Tahoe-x1

Stay up to date with
what we’re releasing.